Fig. 3
From: Synthetic carbohydrate-based vaccines: challenges and opportunities

Structures of the repeating unit of MenC CPS, their synthetic oligosaccharides 15–20 and glycoconjugates 21–28
From: Synthetic carbohydrate-based vaccines: challenges and opportunities
Structures of the repeating unit of MenC CPS, their synthetic oligosaccharides 15–20 and glycoconjugates 21–28